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Background: Transfusion-transmitted infections threaten the safety of patients requiring blood transfusion, which
in turn imposes serious challenges for the availability of safe blood products that are still affordable in health care
systems with limited resources. The aim of the study was to determine the prevalence of transfusion-transmitted
infections in blood donors and to evaluate the demographic characteristics of reactive and non-reactive blood
donors.
Methods: A prospective cohort study was conducted at our institute in Karachi, Pakistan. Donors were required to
fill a detailed questionnaire and were screened for Hepatitis B, Hepatitis C, Human immunodeficiency viruses,
Syphilis and Malaria by ELISA and thick film (malaria).
Results: Of the 16,602 blood donors, 16,557 were males and 45 females (mean age 28.6 ± 2). Nine hundred and
seventy three (5.8%) donations were reactive in any screening assay, with 58 (0.35%) donations reacting in more
than one assay. The prevalence of Hepatitis B, Hepatitis C, Human immunodeficiency viruses, Syphilis and Malaria
was found to be 1.84, 1.7, 0.04, 2.1 and 0.07% respectively. Characteristics among the infections were evaluated
and it was found that unmarried donors had a higher chance to be infected by Hepatitis B virus and Syphilis
as compared to the other infections. On the other hand, construction workers and married donors were at
more risk to be infected by Syphilis rather than the other infections. In case of co-infections, personnel with
different occupations and marital status were infected by more than one pathogen.
Conclusion: A substantial percentage of the blood donor’s harbored transfusion-transmitted infections. Prevention
of TTIs should be the main goal right now. There is a need for stringent selection of blood donors with the
emphasis on getting voluntary donations and comprehensive screening of donor’s blood for TTIs using
standard methods to ensure the safety of blood recipient.
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Blood donation saves the lives of millions of people
worldwide; however, the patients are at a potential risk
of contracting transfusion-transmitted infections (TTIs),
which in turn impose serious challenges to the medical
providers for the availability of safe and affordable blood
products. According to the World health organization
(WHO), safe blood is a universal right. A crucial require-
ment in the procurement of safe blood is to have a* Correspondence: muniraborhany@gmail.com
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tion, and education; this will minimize donations from
donors who might transmit diseases to the recipients.
Equally important is to evaluate the burden and risk
factors for TTIs in the general population [1]. The
accurate figures of TTIs in our population are still un-
known due to the lack of understanding, un-availability of
screening tests, limited access to health facilities and the
unavailability of surveillance systems [2]. Furthermore,
voluntary donors have been reported to be the safest
group of donors because they usually have better health
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out of compassion [3].
In Pakistan, more than 1.5 million units of blood are
collected each year but the majority of these donors are
replacement donors, mostly family members or close
friends of the patient with the intention to help in most
cases for transfusion under emergency situations [4].
There is an immense need to provide safe blood prod-
ucts. This requires high quality transfusion services and
an organized infrastructure along with properly trained
and well-educated staff [2].
The prevalence of Hepatitis B virus (HBV) and Hepa-
titis C virus (HCV) in Pakistan is high and has been
reported earlier (HBV: 2.5% and HCV: 4.9%) [4]. However
recent studies raised concerns regarding the increasing
prevalence in trends of TTIs other than HBV and HCV,
especially Human immunodeficiency viruses (HIV) and
Syphilis [2, 3, 5–8]. The present study provides data on
the overall seroprevalence of TTIs in blood donors and
evaluates the demographic characteristics of seropositive
donors.
Methods
This was a prospective cohort study of blood donors
attending the National Institute of Blood disease and
Bone Marrow transplantation (NIBD) donor’s center from
January 2013 to June 2015. Informed consent was taken
from all donors. Blood donors were given a unique identi-
fication number and their name, age, sex, date of birth,
profession, marital status and contact numbers were re-
corded. Before the donation, each potential donor was
required to fill a detailed health history questionnaire
which included data regarding their general health, life
style, current or past febrile illness, weight loss, chronic
disease, unusual or excessive bleeding, drug history, tattoo
piercing, dental treatment, previous blood donation or
transfusion, history of travel or immigration, sexual his-
tory and risk behaviors followed by short private inter-
views. Vitals and weight were also recorded. Baseline
complete blood count (CBC) was done for excluding
any donors with anemia (<12.5 g/dl), infection or
thrombocytopenia. Moreover, inspection was made for
any marks of drug abuse or any skin lesion at the veni
puncture site. Proper sterilization and other precautions
were taken during blood collection and blood units were
stored using appropriate methods. Blood donors were
then screened for HBV, HCV, HIV, Syphilis and Malaria.
Laboratory tests
Screening for HBsAg, Anti HCV, HIV Ag/Ab (HIV-1/
HIV-2) and Syphilis was done by chemiluminescent
micro particle immunoassay (CMIA) method on Archi-
tect i2000 (Abbott Diagnostic, USA). Furthermore,
Malaria was screened by thick films and through theimmunochromatographic test (ICT) method. Reactive
results were repeated on the same sample using the same
method.
Study subjects inclusion criteria
Physically fit 18–55 year olds who donated blood at
NIBD blood donor center were included.
Study subjects exclusion criteria
Potential donors were excluded if they were: below
18 years old, weigh <50 kg, anemic, had a history of
jaundice, malaria, asthma, engaged in high risk behavior
(i.e. unsafe intercourse, drug abuse), had past history of
HBV, HCV, HIV I & II or syphilis, or were apparently
unhealthy or malnourished.
Statistical analysis
Data was analyzed using SPSS version 21. Infections
among reactive and nonreactive blood donors were
analyzed by using logistic regression and estimates of the
odds ratio with their corresponding 95% confidence inter-
val. Chi Square was applied to find the association of
co-infections with demographic variables. P-value <0.05
was considered significant in all analysis.
Results
A total of 16,602 donors who visited for blood donation
were screened; 16,557 were males and 45 females, with a
mean age of 28.6 ± 2 years (range 18 to 55 years), of
which 95% were replacement blood donors. Of all dona-
tions, 973 (5.8%) were reactive in the screening assays,
among them 58 (0.35%) were reactive in more than one
assay. The prevalence of HCV, HBV, HIV, syphilis and
malaria in our study population was 1.8, 1.7, 0.04, 2.1
and 0.07% respectively. The overall demographic vari-
ables among the reactive and non-reactive donors are
shown in (Table 1). Characteristics among infections
were individually evaluated, as shown in (Table 2). It was
found that unmarried donors were more likely to be
positive for HBV infection (OR-CI: 0.331:0.202-0.570,
P-value: 0.001) and Syphilis (OR-CI: 0.182:0.065-0.512,
P-value: 0.001) rather than the other infections. The
construction workers (OR-CI: 0.219:0.129-0.370, P-value:
0.000) and married persons (OR-CI: 0.360:0.158-0.820,
P-value: 0.015) have a higher chance to be positive for
Syphilis than the other infections. The association of
gender, age groups, education, number of donations,
and residential status was not significant for any of the
studied infections. We observed the trend of co–infections
(risk to be infected by more than one pathogens) in the
sub categories of our donors and it was found that the
subcategory of occupation (P-value = 0.01) and the subcat-
egory of marital status (P-value = 0.00) were significant.
(Table 3)
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Blood transfusion is a life-saving procedure of modern
medicine. Stringent screening of blood not only gives us
an idea about the prevalence of TTIs in healthy popula-
tions but also ensures the safe supply of blood and blood
products. [9]. Disease burden estimations based on
sound epidemiological research form the basis of public
policy. Similarly, the exact evaluations of the risk of TTIs
is imperative in order to monitor the safety of blood
supply and gauging the effectiveness of the presently
employed screening procedures, as discussed by Busch
et al. [10]. According to one study, in Pakistan the ma-
jority of the blood donors are first timers, which can be
considered a true reflection of infection amongst the
community [9]. However, according to other studies,
blood donors may not represent the general population
as the prevalence rate may be underestimated or overes-
timated due to their different characteristics [11, 12].Since most of them are male, young or middle-aged, the
source of prevalence may underestimate the actual
prevalence. This view seems more valid as opposed to
the previous one simply because females comprise more
than 50% of Pakistan’s population. The prevalence of
TTIs among blood donors in a well-structured health
care system coupled with a well-organized blood estab-
lishment can be used as a reliable tool for statistical
calculation of those infectious agents that can be trans-
mitted through blood products in the populations, as
discussed by Gharehbaghian and Chandra et al. [1, 13].
In our study, most of the donors were replacement
blood donors i.e. 95% which is comparable with other
local studies in which majority of blood donations were
contributed by replacement donors [4, 14] with the
intention to help a friend, relative or acquaintance who
needed blood transfusion. The maximum number of
donors came from the 18–30 year age group. A similar
trend was seen in earlier reports [15, 16]. Furthermore,
efforts should also be made to encourage and improve
the number of female donors, as our study shows limited
number of female donors. In this study, a significant
increase in the seroprevalence of syphilis was observed
among blood donors over the study period, which was
found to be 2.1%. A local study that was done previously
had also observed a rising seroprevalence of 0.89% [17].
This finding is consistent with the increasing trend of
syphilis seropositivity observed in blood donors of Israel
[18]. A study done in Iran also found a rising trend
of syphilis frequency in their population; however, the
frequency found in this study was 0.04% [19]. Previous
local data shows low seroprevalence from 0.22 to 0.89%,
which is contrary to that observed in our study [4, 20–22].
Another study found a downward trend in seroprevalence
[3]. Moreover, Moiz et al. observed similar results in their
study [23]. Furthermore, studies done in India had very
low prevalence as compared to our study [15, 24]. Thus,
the seroprevalence of syphilis in blood donors observed
in our study was high as compared to the previous local
and international data. Since citizens perform blood
donation(s), it could provide an updated picture about
prevalence of Syphilis in the Pakistani population.
However, one of the limitations in our study is that
positivity of Syphilis could not be further validated by
confirmatory assay and positivity could only give indica-
tion as a surrogate marker.
There is also limited surveillance data for HIV in
Pakistan. Current study reports the figure of 0.04%,
which is slightly higher than the one reported in studies
by Attaullah, Manzoor and Sultan et al. [2, 4, 21]. HIV
positive blood units were confirmed with other tech-
niques in the reference HIV laboratory.
Acute and chronic viral hepatitis are the most reported
health problems in Pakistan and usually bring with them
Table 2 Demographic variables of individual Infections among reactive and non-reactive blood donors
Characteristics HBsAg (n=290) Anti HCV (n=307) MP (n=12) Syphilis (n=357)
Non react. React P-value Non Ract. React P-value Not seen Seen P-value Non react. React P-value
Age groups
18–25 8314 156 0.847 8340 131 0.616 8468 7 0.987 8291 170 0.177
26–35 6394 111 0.745 6364 144 0.063 6501 5 0.988 6357 154 0.357
More than 35* 1604 23 1591 32 1629 0 1597 33 0.861
Gender
Female 45 0 0.998 44 1 0.504 45 0 0.998 45 0 0.998
Male* 16267 290 16251 306 16541 12 16186 357
Occupation
Student* 1508 54 2496 54 1770 0 2077 36
Businessman 4076 77 0.924 3796 77 0.986 3182 5 0.999 3727 28 0.220
Driver 3776 52 0.977 3596 61 0.997 4753 3 0.997 3486 50 0.593
Office Employee 2776 32 0.982 2848 41 0.996 3640 0 0.97 3736 22 0.989
Construction worker/laborer 4176 75 0.977 3559 74 0.997 3245 4 0.995 3219 221 0.000
Education
Illiterate* 6408 169 0.975 5242 178 0.972 6185 6 0.095 5192 233 0.686
Literate 9904 121 11053 129 10405 6 11053 124
Number of donations
Repeat donation* 4783 106 0.986 4506 134 0.984 6203 2 0.936 4419 128 0.053
First donation 11529 184 11789 173 10387 10 11826 229
Marital status
Divorced* 2259 74 1480 81 4873 1 1513 13
Unmarried 8327 136 0.00 7765 146 0.985 7911 5 0.959 7837 83 0.001
Married 5726 80 0.987 7050 80 0.979 3806 6 0.938 6895 261 0.015
Residential status
Rural 5852 103 0.994 7748 158 0.999 6802 6 0.948 7670 267 0.826
Urban* 10460 187 8547 149 9788 6 8575 90
*reference category
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lence of HBV and HCV infections among healthy blood
donors is well recognized [12, 14, 17, 25] except by the
Mahmood et al. study [26], which shows less percentage
of HBsAg and anti HCV.
Risk behavior–based donor selection is the cornerstone
of the availability of safe blood. It is dependent on donor
education as well as the accurate and truthful disclosure of
risk behavior [12]. In our study, risk factors were assessed
using a questionnaire but many blood donors were reluc-
tant to disclose any risk behavior(s) because of the potential
fear of judgment, embarrassment, test-seeking behavior, or
due the genuine belief that their blood was safe [12]. We
have over all observed risk factors among the blood donors
in our study however they were not analyzed for each blood
donor’s category individually. Therefore, we could only
simulate risk factors among blood donors based on local
studies on HBV and HCV infections [11, 12].The focus of our study was also to determine the
demographic characteristics of reactive blood donors.
Positive donors for any infection were informed and
requested to visit general physicians. A short interview
was conducted to find more details regarding the life
styles of reactive blood donors. This is the first local
study in our region, which shows detailed demographic
characteristics information regarding blood donors.
Conclusion
A substantial percentage of the blood donor’s harbored
transfusion transmitted infections. Prevention of TTIs
should be the main goal right now. There is a need for
stringent selection of blood donors with the emphasis
on getting voluntary donations and comprehensive
screening of donor’s blood for HCV, HBV, HIV, Syphilis
and Malaria using standard methods to safeguard the
blood recipient. By assessing the rising trend of Syphilis
Table 3 Association of Co-infections with demographic
variables
Characteristics Co-Infections (N = 58)
Non reactive Reactive P-value
Age groups
18–25 8446 30 (0.35%) 0.791
26–35 6491 21 (0.32%)
More than 35 1607 7 (0.43%)
Gender
Female 45 0 0.691
Male 16,499 58 (0.35%)
Occupation
Student 1433 4 (0.27%) 0.01
Businessman 4080 6 (0.14%)
Driver 3755 23 (0.61%)
Office employee 2735 12 (0.43%)
Construction worker/laborer 4177 13 (0.31%)
Education
Illiterate 6597 29 (0.43%) 0.11
Literate 9947 29 (0.29%)
Number of donations
Repeat donation 4899 17 (0.34%) 0.95
First donation 11,624 41 (0.35%)
Marital status
Divorced 1954 19 (0.97%) 0.00
Unmarried 8141 22 (0.27%)
Married 5585 17 (0.30%)
Residential status
Rural 5974 28 (0.46%) 0.54
Urban 10,570 30 (0.28%)
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blood donor’s population and the population at risk. A
future study is also planned to assess the knowledge,
attitude and behavior of the blood donor’s population.
These measures will improve public health and would
increase blood safety and quality.
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